DOCSLIB.ORG

New Neighbors: 2016 Update Chinese Investment in the United States by Congressional District

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
New Neighbors: 2016 Update Chinese Investment in the United States by Congressional District * New Neighbors: 2016 Update Chinese Investment in the United States by Congressional District A Report by the National Committee on U.S.-China Relations April 2016 and Rhodium Group The map on the cover page depicts the cumulative value of Chinese FDI transactions from 2000 to 2015 in each of the 435 districts of the 114th United States Congress. See Figure 4 for more information. New Neighbors: 2016 Update Chinese Investment in the United States by Congressional District April 2016 A Report by the National Committee on U.S.-China Relations and Rhodium Group www.ncuscr.org/fdi © 2016 National Committee on U.S.-China Relations About this Report About the National Committee on U.S.-China Relations The National Committee on United States-China Relations (NCUSCR) is a private, nonpartisan, American non-profit organization that promotes understanding and cooperation between the United States and Greater China in the belief that sound and productive Sino-American relations serve vital American and world interests. Since its founding in 1966, the Committee has created opportunities for informed discussion and reasoned debate about issues of common interest and concern to the United States, Mainland China, Hong Kong and Taiwan. NCUSCR currently organizes programs for private and public sector participants on politics and security, governance and civil society, economics and finance, education, and transnational issues such as energy and environment. It carries out its mission via conferences and forums, public education programs, professional exchanges and collaborative projects. About Rhodium Group Rhodium Group (RHG) is an economic research firm that combines policy experience, quantitative economic tools and on-the-ground research to analyze disruptive global trends. It supports the investment management, strategic planning and policy needs of clients in the financial, corporate, non-profit, and government sectors. RHG has offices in New York, California and Washington, and associates in Shanghai and New Delhi. RHG’s cross-border investment practice analyzes the rise of China and other emerging markets as trans-national investors. RHG senior staffs publish frequently on the growth and impact of Chinese outbound FDI in the United States, and maintain the China Investment Monitor, a unique database tracking Chinese investment in the US economy. Supported by: Contents Foreword .................................................................................................................... 1 1. Chinese Investment Trends in 2015 ........................................................................... 2 2. Mapping the US Operations of Chinese Companies ................................................... 8 2.1 The Northeast .............................................................................................................. 9 2.2 The Midwest ............................................................................................................... 18 2.3 The South ................................................................................................................... 31 2.4 The West .................................................................................................................... 44 References ................................................................................................................ 53 Data Appendix .......................................................................................................... 55 Methodology ................................................................................................................... 55 Detailed Data ................................................................................................................... 57 Foreword As the National Committee on U.S.-China Relations households missed out on hundreds of millions of dollars celebrates our fiftieth anniversary, we reflect on how in additional payouts. much deeper, more important and complex the Sino- American relationship has grown in each successive The United States remains the world’s most innovative decade of our existence. Our work with NGOs, economy and attractive investment destination, and policymakers, business leaders, and educators has Chinese companies are taking notice. Chinese investors expanded beyond anything our founders could have are drawn to our shores in greater and greater numbers imagined. because of our innovation clusters, IPR protection, and highly educated and motivated talent pools. They also From the moment the National Committee hosted the see the value in getting closer to their customers, as Chinese ping-pong team in 1972 – as part of the historic evidenced by companies like Fuyao Glass, the largest Ping-Pong Diplomacy that led to the restoration of auto glass manufacturer in the world, building facilities diplomatic relations after nearly 30 years – our in Moraine, Ohio, and Decatur, Illinois, to serve the organization became a major bridge for people-to-people domestic market. exchange. With the publication of New Neighbors: 2016 Update, we are pleased to highlight a relatively new and With a record-setting 2.56 million outbound trips from increasingly important bridge: the rapid growth of China to the United States last year – a number that is Chinese investment in the United States. poised to double by 2020 – Chinese companies are investing heavily in the U.S. hospitality and travel After China’s opening up in 1979, the people-to-people logistics sector to meet this growth. In addition, major contact fostered by US companies making investments in new investments in energy and entertainment in 2015 China strengthened our mutual understanding. I had the show Chinese investment facilitating the export of privilege of helping build those bridges as a young lawyer American goods and services to China. living in China. Last year was a record year for Chinese investment in the Today’s Chinese investment in the United States gives us United States, with more than $15 billion in transactions. a fresh opportunity to learn about one another, and it is That record is on course to be shattered in 2016, with over already having profound effects on the lives of $30 billion in pending deals and projects announced in Americans. While much of this year’s political campaign just the first quarter. As Chinese investment continues to rhetoric has focused on jobs leaving the United States, accelerate, the National Committee on U.S.-China Chinese investment is supporting more and more jobs on Relations is confident that this updated New Neighbors this side of the Pacific – over 90,000 and growing. report will help American citizens and leaders at the national, regional, and local levels better understand the It is also worth noting what Chinese investment does for impact of Chinese investments on their communities. asset prices in the United States and who benefits from those increased asset prices and distributions. When a Chinese company pays top dollar to acquire a public US company, the US company’s shareholders generally Stephen A. Orlins receive cash in excess of the stock price. Given that the President, National Committee on U.S.-China Relations largest owners of US stocks are American pension funds and households, it follows that the purchase benefits accrue primarily to American retirees and households. Conversely, when a Chinese acquisition is rejected and a lower bid is accepted, these same people receive less money for their retirements and lives. In the most famous example, in 2005, the lower offer that Union Oil Company of California (UNOCAL) accepted from Chevron rather than China National Offshore Oil Corporation (CNOOC) meant that American retirees and NEW NEIGHBORS 1 1. Chinese Investment Trends Last year’s “New Neighbors” report for the first time Acquisitions still dominate but greenfield FDI surges provided a detailed tally of the operations of Chinese- affiliated companies in the United States and the local Mergers and acquisitions (M&A) continue to be the impacts of those investments. This update reviews preferred entry mode for Chinese investors in the US China’s US investments in 2015 and describes how they market as they seek fast growth. For the second year in a have affected the footprint of Chinese companies in each row, Chinese companies completed more than 100 M&A region, state, and congressional district. deals in the US, totaling $13.5 billion. The biggest transactions were Fosun’s purchase of Ironshore Chinese investment in acquisitions, new operations, and Insurance ($2.4 billion), Anbang’s acquisition of the expansions in the US grew to more than $15 billion in Waldorf Astoria hotel in New York ($1.95 billion), Yantai 2015, setting a new record. The number of Chinese- Xinchao’s investment in Texas oil fields ($1.3 billion), and affiliated companies in the US exceeded 1,900 by year- a consortium’s purchase of semiconductor firm end, extending across more than 80% of congressional Integrated Silicon Solutions ($800 million). districts (362 of 435). As greenfield foreign direct investment (FDI) picked up and many existing Figure 1: Chinese FDI Transactions in the US by Entry Mode companies expanded local employment, the number of Number of deals, USD million Americans employed by Chinese-affiliated companies Value of Acquisitions (Right Axis) 16,000 100 rose by another 12% to 90,000. Value of Greenfield Projects (Right Axis) 14,000 Number of Greenfield Projects (Left Axis) 12,000 80 Number of Acquisitions (Left
Load more

Recommended publications
  • Annual Abortion Report 2015
    MICHIGAN DEPARTMENT OF HEALTH & HUMAN SERVICES Division for Vital Records and Health Statistics INDUCED ABORTIONS IN MICHIGAN January 1 through December 31, 2015 Rick Snyder, Governor Nick Lyon, Director LANSING, MICHIGAN MAY 2016 Table Of Contents Introduction 1 Trends Table A Number, Ratio & Rate of Reported Induced Abortions Occurring in Michigan, 1982-2015 4 Table B-1 Abortions by Woman's Age, Gestational Age, Procedure, Facility Type & Complications, 1985-2015 5 Table B-2 Abortions by Woman's Age, Marital Status, Previous Pregnancy Outcome, 1985-2015 6 Table C Number, Ratio & Rate of Reported Induced Abortions, United States, 1980-2012 7 Table D Number of Reported Induced Abortions by Age of Woman, Michigan Residents, 1983-2015 8 Table E Number of Reported Abortions by Selected Characteristics, Michigan Residents, 1980-2015 9 Table F Number, Ratio & Rate of Reported Induced Abortions, Michigan Residents, 1982-2015 10 Table G-1 Abortion Numbers by County of Residence Counties & Detroit City, 2005-2015 11 Table G-2 Abortion Rates by County of Residence & Detroit City 2005-2015 14 Induced Abortions Statistics for Michigan Residents, 2015 Table 1 Abortions by County of Residence 17 Table 2 Abortions by County of Residence & Age of Woman 18 Table 3-A Abortions by City of Residence & Age of Woman for Cities with Over 40,000 Population 21 Table 3-B Abortions by Area of Residence & Age of Woman for Selected Large Metropolitan Areas 23 Table 4 Abortions by County of Residence & Number of Previous Induced Abortions 24 Table 5 Abortions by Age
    [Show full text]
  • Annual Report
    2020 (Incorporated in Hong Kong with limited liability) (Stock Code : 00656) Annual Report Profit Attributable to Owners of the Parent RMB 8,017.9 million Innovation & Win The year 2020 might be the most challenging year for Fosun, yet it was also the best year. After the pandemic, we continue with the “wartime mechanism” and maintain the fighting spirit that we have developed during the global combat against COVID-19. This has resulted in our resilient business performance throughout the year. The pandemic has also allowed us to refine further our capabilities of the Company accumulated over the years for “Industry Operations + Industrial Investment”, FC2M model, globalization and technology innovation. Fosun has thus evolved and become even stronger. The theme of Fosun’s annual report this year is “Innovation & Win”. “Innovation” means Fosun always attaches great importance to innovation. We recognize that we can create world-class products only by increasing investment in innovation and R&D. It is also because of our investment in technology innovation in various industries over the years, as well as leveraging on Fosun’s diversified and globalized business portfolio, the development model of “Industry Operations + Industrial Investment”, and the “wartime” mode that it has upkept since the battle against the pandemic, that together effectively defended the impact brought by the external environment and brought the Group a resilient performance, thereby creating mutually beneficial and win-win situation to all stakeholders. The year 2021 is a new starting point for Fosun’s transformation. Facing the huge opportunities in the industrial internet era, we will continue to create good products and put the operation of customers (C-end) as our top priority to fully unlock the multiplier growth of good products and customer resources in Fosun’s ecosystem.
    [Show full text]
  • Biontech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine
    BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine January 25, 2021 COMIRNATY® (also known as BNT162b2, Chinese product name: 復必泰TM) is the first COVID-19 vaccine to receive Authorization for Emergency Use in Hong Kong MAINZ, GERMANY, and SHANGHAI, CHINA, January 25, 2021 —BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “Group”; Stock Code: 600196.SH, 02196.HK) today announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC (“Hong Kong”), the COVID-19 vaccine COMIRNATY® (also known as BNT162b2, Chinese product name: 復必泰TM) based on BioNTech’s proprietary mRNA technology has received authorization for emergency use in Hong Kong. The vaccine will be produced in BioNTech’s manufacturing facilities in Germany and supplied to Hong Kong for administration under the Hong Kong SAR Government’s COVID-19 Vaccination Program. “We are excited and encouraged that COMIRNATY® has been authorized to emergency use in Hong Kong. This is an important milestone in the joint efforts of BioNTech and Fosun Pharma to achieve vaccine accessibility globally. We will continue working closely with BioNTech to complete the ongoing clinical trial and marketing registration in Greater China,” Wu Yifang, Chairman and CEO of Fosun Pharma said. “We will also cooperate closely with HKSAR regarding vaccination deployment plan to ensure that Hong Kong citizens can receive a well-tolerated and effective mRNA COVID-19 vaccine as soon as possible in order to protect the health of millions of households.” On 16 March 2020, BioNTech and Fosun Pharma announced a strategic collaboration to work jointly on the development and commercialization of a COVID-19 vaccine product in Greater China based on BioNTech’s proprietary mRNA technology platform.
    [Show full text]
  • ACAL China Equity Nov17
    ARETE CAPITAL ASIA CHINA: VALUE IN SELECTED NAMES CHINA EQUITY – OVERVIEW CHINA IS TAKING ITS PLACE ON THE WORLD STAGE • China is a critical player in the world economy and is the worlds largest economy on a purchasing power parity basis. • Xi’s position has been reinforced for the next 5yrs and possibly beyond. The new leadership will retain existing key policies with a focus on economic reform and an emphasis on foreign policy. ECONOMIC TRANSFORMATION WELL UNDERWAY • ‘Smokestack’ industries (coal, aluminium and steel) and ‘providing for populace’ businesses (consumer staples and healthcare) are no longer so dominant and being overtaken by manufacturers and service companies. • In many cases, these new ‘service’ industries are redefining business models in established sectors • The China government has selected and carefully encouraged special policies/industries to have Chinese operations challenge the established order – internally and externally INVESTMENT OPPORTUNITIES EXIST • Amongst the many transformations taking place in China, there are numerous great investment opportunities. We do not recommend an index, but selected stocks • Some of these stocks have made significant gains over the last 12months, but there is still more to come 2 CONTENT OVERVIEW ECONOMY Economy Issues Diversification 4 5 6 Equities Remninbi VALUATIONS 7 8 SITUATIONS MiddlePORTFOLIO Class ecosystem ADVISORY 9 10 SELECTED STOCKS Preferred 11 Valuations 13 3 CHINA – ECONOMY CHINA’s ECONOMIC GROWTH REMAINS RESILIENT … • IMF forecasts (not a leading indicator)
    [Show full text]
  • Hang Seng Indexes Announces Index Review Results
    14 August 2020 Hang Seng Indexes Announces Index Review Results Hang Seng Indexes Company Limited (“Hang Seng Indexes”) today announced the results of its review of the Hang Seng Family of Indexes for the quarter ended 30 June 2020. All changes will take effect on 7 September 2020 (Monday). 1. Hang Seng Index The following constituent changes will be made to the Hang Seng Index. The total number of constituents remains unchanged at 50. Inclusion: Code Company 1810 Xiaomi Corporation - W 2269 WuXi Biologics (Cayman) Inc. 9988 Alibaba Group Holding Ltd. - SW Removal: Code Company 83 Sino Land Co. Ltd. 151 Want Want China Holdings Ltd. 1088 China Shenhua Energy Co. Ltd. - H Shares The list of constituents is provided in Appendix 1. The Hang Seng Index Advisory Committee today reviewed the fast expanding innovation and new economy sectors in the Hong Kong capital market and agreed with the proposal from Hang Seng Indexes to conduct a comprehensive study on the composition of the Hang Seng Index. This holistic review will encompass various aspects including, but not limited to, composition and selection of constituents, number of constituents, weightings, and industry and geographical representation, etc. The underlying aim of the study is to ensure the Hang Seng Index continues to serve as the most representative and important benchmark of the Hong Kong stock market. Hang Seng Indexes will report its findings and propose recommendations to the Advisory Committee within six months. The number of constituents of the Hang Seng Index may increase during this period. Hang Seng Indexes Announces Index Review Results /2 2.
    [Show full text]
  • China Pharmaceuticals China Pharmaceuticals Spring Is in the Air – We Expect a Year of Healthy Growth
    EQUITIES HEALTHCARE March 2017 By: Zhijie Zhao https://www.research.hsbc.com China Pharmaceuticals China China Pharmaceuticals Spring is in the air – we expect a year of healthy growth The policy pain of 2016 starts to ease and the industry’s fundamentals remain robust Multinational companies are reducing their focus on off-patent drugs in China, opening up a range Equities // Healthcare // Equities of opportunities We raise our target prices between 11% and 25%; we prefer Hengrui, Sino Biopharm and CMS, all rated Buy March 2017 March Disclaimer & Disclosures: This report must be read with the disclosures and the analyst certifications in the Disclosure appendix, and with the Disclaimer, which forms part of it EQUITIES ● HEALTHCARE March 2017 THIS CONTENT MAY NOT BE DISTRIBUTED TO THE PEOPLE'S REPUBLIC OF CHINA (THE "PRC") (EXCLUDING SPECIAL ADMINISTRATIVE REGIONS OF HONG KONG AND MACAO) The dark clouds are lifting The pain is easing as the risks associated with industry reforms recede We forecast that the net profit growth of our covered companies will average 19% in 2017e and 23% in 2018e, up from 18% in 2016e We raise our target prices by 11-25%; we prefer Hengrui, Sino Biopharm and CMS, all rated Buy Last year we wrote that China’s attempts to improve the healthcare system were proving painful for pharma companies (China Pharmaceuticals – 2016: Painful symptoms, possible remedies, 1 March 2016). We said that, although efforts to cut the cost of healthcare and improve industry standards would make the first half of 2016 difficult, we remained strong believers in China’s pharma story.
    [Show full text]
  • 股 份 有 限 公 司 Shanghai Fosun Pharmaceutical (Group) Co
    THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to any aspect of this circular or as to the action to be taken, you should consult a stockbroker or other registered dealer in securities, bank manager, solicitor, professional accountant or other professional adviser. If you have sold or transferred all your shares in Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*, you should at once hand this circular, together with the enclosed form of proxy, to the purchaser(s) or transferee(s) or to the bank, stockbroker or other agents through whom the sale or transfer was effected for transmission to the purchaser(s) or transferee(s). Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this circular. 上 海 復 星 醫 藥（ 集 團 ）股 份 有 限 公 司 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 02196) REPORT ON THE USE OF PROCEEDS PREVIOUSLY RAISED AND NOTICE OF EGM A letter from the Board is set out on pages 3 to 5 of this circular. The notice convening the EGM of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* to be held at 1:30 p.m. on Wednesday, 14 July 2021 at Shanghai Film Art Center, No.
    [Show full text]
  • Xiaomi Sews up Deals for Smart Homes
    16 BUSINESS Thursday, November 29, 2018 CHINA DAILY HONG KONG EDITION Xiaomi sews Shenzhen firms hike investment up deals for in R&D sector By ZHOU MO in Shenzhen, Guangdong smart homes [email protected] 20 percent of Shenzhen­registered list­ Tech tie­ups with Ikea, Microsoft and Nearly 20 percent of ed companies devoted more Shenzhen­registered listed than 10 percent of their iKongjian ‘to create better life for people’ companies devoted more operating revenue to R&D than 10 percent of their oper­ By OUYANG SHIJIA shortly after Ikea, the world’s ating revenue to research ouyangshijia@ largest furniture retailer, said and development last year, a chinadaily.com.cn last week that it would acceler­ level on par with globally ate its transformation to fully leading high­tech enterpris­ the sector that took the lead. Chinese technology giant embrace new technologies and es like Google and Apple, Of the 10 listed companies Xiaomi Corp announced on offer better user experiences. according to a report. with the biggest R&D invest­ Wednesday it has teamed up Bjorn Block, business leader In all, 256 companies cov­ ment, eight were IT compa­ with Sweden’s furniture titan for Ikea’s Home Smart divi­ Lei Jun, founder and CEO of Xiaomi Corp, delivers a speech on Wednesday during the MIDC Xiaomi ered in the Shenzhen­regis­ nies. Ikea to offer smart home prod­ sion, told during the confer­ AIoT Developer Conference in Beijing. PROVIDED TO CHINA DAILY tered Listed Companies The R&D investment of ucts. ence that the new partnership Development Report dis­ Tencent Holdings Ltd, the The tie­up is part of its larg­ marked a key step in creating a closed their R&D spending world’s largest game maker er efforts to expand into the seamless experience for cus­ partnership would benefit home renovation service plat­ in their 2017 annual reports.
    [Show full text]
  • 2016 Annual Report (PDF)
    Table of Contents 2 Corporate Information 3 CEO’s Statement 6 Management Discussion and Analysis 23 Biographies of Directors and Senior Management 27 Corporate Governance Report 39 Report of the Directors 59 Independent Auditor’s Report 64 Consolidated Statement of Profit or Loss and Other Comprehensive Income 65 Consolidated Statement of Financial Position 67 Consolidated Statement of Changes in Equity 68 Consolidated Statement of Cash Flows 70 Notes to the Consolidated Financial Statements 166 Five-year Financial Summary Corporate Information BOARD OF DIRECTORS REGISTERED OFFICE Executive Directors Maples Corporate Services Limited PO Box 309 Ms. GAO Lina (Deputy Chairman and Chief Executive Officer) Ugland House Mr. HAN Chunlin (Chief Operation Officer) Grand Cayman, KY1-1104, Cayman Islands Non-Executive Directors HONG KONG OFFICE Mr. YU Xubo (Chairman) Unit 2402, 24/F, Mr. WOLHARDT Julian Juul Alliance Building 130-136 Mr. HUI Chi Kin, Max Connaught Road Central Sheung Wan Mr. ZHANG Ping Hong Kong Mr. SUN Yugang PRINCIPAL SHARE REGISTRAR AND Independent Non-Executive Directors TRANSFER OFFICE Mr. LI Shengli Maples Finance Limited Mr. LEE Kong Wai, Conway PO Box 1093, Mr. KANG Yan Queensgate House Mr. ZOU Fei Grand Cayman, KY1-1102 Cayman Islands AUDIT COMMITTEE HONG KONG BRANCH SHARE REGISTRAR Mr. LEE Kong Wai, Conway (Chairman) AND TRANSFER OFFICE Mr. HUI Chi Kin, Max Mr. ZOU Fei Computershare Hong Kong Investor Services Limited Rooms 1712-1716, 17/F, Hopewell Centre REMUNERATION COMMITTEE 183 Queen’s Road East Wanchai Hong Kong Mr. LI Shengli (Chairman) Mr. WOLHARDT Julian Juul LEGAL ADVISORS Mr. ZOU Fei NOMINATION COMMITTEE As to Hong Kong Law Mr.
    [Show full text]
  • Annual Report Contents
    2017 ANNUAL REPORT CONTENTS Corporate Information 2 Results Highlights 4 Chairman’s Statement 6 Biographies of Directors and Senior Management 8 Business Review 16 Financial Review 26 Corporate Governance Report 35 Directors’ Report 46 Independent Auditor’s Report 58 Consolidated Statement of Profit or Loss and 63 Other Comprehensive Income Consolidated Statement of Financial Position 65 Consolidated Statement of Changes in Equity 67 Consolidated Statement of Cash Flows 69 Notes to the Consolidated Financial Statements 71 Five year Summary 162 Glossary 164 CORPORATE INFORMATION Legal Name of the Company Company Secretary WH Group Limited Mr. CHAU Ho Place of Listing and Stock Code Audit Committee The shares of the Company were listed on the Main Board Mr. LEE Conway Kong Wai (Chairman) of the Stock Exchange on August 5, 2014 Mr. HUANG Ming Mr. LAU, Jin Tin Don Stock Code: 288 Remuneration Committee Company Website Mr. HUANG Ming (Chairman) www.wh-group.com Mr. LEE Conway Kong Wai Mr. JIAO Shuge Directors Executive Directors Nomination Committee Mr. WAN Long (Chairman and Chief Executive Officer) Mr. WAN Long (Chairman) Mr. GUO Lijun (Executive Vice President and Chief Mr. HUANG Ming Financial Officer) Mr. LAU, Jin Tin Don Mr. ZHANG Taixi (General Manager of Shuanghui Group) Mr. SULLIVAN Kenneth Marc (President and Chief Environmental, Social and Executive Officer of Smithfield) Governance Committee Mr. YOU Mu (Vice President of Shuanghui Development) Mr. GUO Lijun (Chairman) Mr. SULLIVAN Kenneth Marc Non-executive Director Mr. ZHANG Taixi Mr. JIAO Shuge (Deputy Chairman) Mr. LAU, Jin Tin Don Independent Non-executive Directors Food Safety Committee Mr.
    [Show full text]
  • Annual Report – October 31 2018
    THE CHINA FUND, INC. ANNUAL REPORT October 31, 2018 The China Fund, Inc. Table of Contents Page Key Highlights 1 Asset Allocation 2 Industry Allocation 3 Chairman’s Statement 4 Investment Manager’s Statement 7 About the Portfolio Manager 9 Schedule of Investments 10 Financial Statements 14 Notes to Financial Statements 18 Report of Independent Registered Public Accounting Firm 26 Other Information 27 Dividends and Distributions: Summary of Dividend Reinvestment and Cash Purchase Plan 29 Directors and Officers 33 THE CHINA FUND, INC. KEY HIGHLIGHTS (unaudited) FUND DATA NYSE Stock Symbol CHN Listing Date July 10, 1992 Shares Outstanding 15,722,675 Total Net Assets (10/31/18) $298,469,072 Net Asset Value Per Share (10/31/18) $18.98 Market Price Per Share (10/31/18) $16.98 TOTAL RETURN(1) Performance as of 10/31/18: Net Asset Value Market Price 1-Year Cumulative -16.55% -17.53% 3-Year Cumulative 10.26% 12.29% 3-Year Annualized 3.31% 3.94% 5-Year Cumulative 18.71% 20.78% 5-Year Annualized 3.49% 3.85% 10-Year Cumulative 176.01% 169.92% 10-Year Annualized 10.69% 10.44% DIVIDEND HISTORY Record Date Income Capital Gains 12/19/17 $0.5493 — 12/19/16 $0.4678 — 12/28/15 $ 0.2133 $ 1.2825 12/22/14 $ 0.2982 $ 3.4669 12/23/13 $ 0.4387 $ 2.8753 12/24/12 $ 0.3473 $ 2.9044 12/23/11 $ 0.1742 $ 2.8222 12/24/10 $ 0.3746 $ 1.8996 12/24/09 $ 0.2557 — 12/24/08 $ 0.4813 $ 5.3361 (1) Total investment returns reflect changes in net asset value or market price, as the case may be, during each period and assumes that dividends and capital gains distributions, if any, were reinvested in accordance with the dividend reinvestment plan.
    [Show full text]
  • Michigan Developmental Disabilities Council Five- Year State Plan 2017-2021
    Michigan Developmental Disabilities Council Five- Year State Plan 2017-2021 Kristen E. Columbus, Chairperson Vendella M. Collins, Executive Director Michigan Developmental Disabilities Council 320 S. Walnut Lansing, MI 48913 TABLE OF CONTENTS Statement of Values .................................................................................................................................... 4 Section I: Council Identification ................................................................................................................ 6 Section II: Designated State Agency .......................................................................................................... 8 Section III: Comprehensive Review and Analysis ................................................................................... 9 Introduction ............................................................................................................................................. 9 PART A: State Information ................................................................................................................. 11 PART B: Portrait of the State Services ............................................................................................... 11 Michigan Department of Career Development ..................................................................... 14 Client Assistance Program ................................................................................................ 14 Michigan Department of Civil Rights ..................................................................................
    [Show full text]